論文- 石井 直人 -
表示方法: 表示形式: 表示順:
件数:107件
[2018]
1.OX40 costimulation inhibits Foxp3 expression and Treg induction via BATF3-dependent and independent mechanisms.[Cell Report,24,(2018),607-618]Zhang X, Xiao X, Lan P, Li J, Dou Y, Chen W, Ishii N, Chen S, Xia B, Chen K, Taparowsky E, Li XC
2.TNF receptor associated factor 5 controls oncostatin M-mediated lung inflammation..[Biochemical and biophysical research communications,499(3),(2018),544-550]Machiyama T, So T, Okuyama Y, Kobayashi S, Phung HT, Asao A, Harigae H, Ishii N
10.1016/j.bbrc.2018.03.186
http://www.ncbi.nlm.nih.gov/pubmed/29596835
3.GITR cosignal in ILC2s controls allergic lung inflammation..[The Journal of allergy and clinical immunology,141(5),(2018),1939-1943.e8]Nagashima H, Okuyama Y, Fujita T, Takeda T, Motomura Y, Moro K, Hidaka T, Omori K, Sakurai T, Machiyama T, Ndhlovu LC, Riccardi C, So T, Ishii N
10.1016/j.jaci.2018.01.028
http://www.ncbi.nlm.nih.gov/pubmed/29427641
4.TRAF2 and TRAF5 Associated with the Signal Transducing Receptor gp130 Limit IL-6-driven Transphosphorylation of JAK1 through the Inhibition of Proximal JAK-JAK Interaction..[International immunology,(2018)]Kimura M, Nagashima H, Okuyama Y, Ishii N, So T
10.1093/intimm/dxy029
http://www.ncbi.nlm.nih.gov/pubmed/29668931
5.Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4<sup>+</sup> T Cells..[Frontiers in immunology,9,(2018),1986-]Nagashima H, Ishii N, So T
10.3389/fimmu.2018.01986
http://www.ncbi.nlm.nih.gov/pubmed/30214449
6.Bmi1 Regulates IκBα Degradation via Association with the SCF Complex.[J. Immunol.,in press,(2018)]Okuyama Y, Tanaka Y, Jiang JJ, Kamimura D, Nakamura A, Ota M, Ohki T, Higo D, Ogura H, Ishii N, Atsumi T, Murakami M
[2017]
7.Inflammatory responses induce an identity crisis of alveolar macrophages, leading to pulmonary alveolar proteinosis..[The Journal of biological chemistry,292(44),(2017),18098-18112]Ebina-Shibuya R, Matsumoto M, Kuwahara M, Jang KJ, Sugai M, Ito Y, Funayama R, Nakayama K, Sato Y, Ishii N, Okamura Y, Kinoshita K, Kometani K, Kurosaki T, Muto A, Ichinose M, Yamashita M, Igarashi K
10.1074/jbc.M117.808535
http://www.ncbi.nlm.nih.gov/pubmed/28916727
8.TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury..[The Journal of clinical investigation,127(6),(2017),2222-2234]Lan P, Fan Y, Zhao Y, Lou X, Monsour HP, Zhang X, Choi Y, Dou Y, Ishii N, Ghobrial RM, Xiao X, Li XC
10.1172/JCI91075
http://www.ncbi.nlm.nih.gov/pubmed/28436935
9.CD103<sup>+</sup> CD11b<sup>-</sup> salivary gland dendritic cells have antigen cross-presenting capacity..[European journal of immunology,47(2),(2017),305-313]Lu L, Tanaka Y, Ishii N, Sasano T, Sugawara S
10.1002/eji.201646631
http://www.ncbi.nlm.nih.gov/pubmed/27861804
10.ER Stress Protein CHOP Mediates Insulin Resistance by Modulating Adipose Tissue Macrophage Polarity..[Cell reports,18(8),(2017),2045-2057]Suzuki T, Gao J, Ishigaki Y, Kondo K, Sawada S, Izumi T, Uno K, Kaneko K, Tsukita S, Takahashi K, Asao A, Ishii N, Imai J, Yamada T, Oyadomari S, Katagiri H
10.1016/j.celrep.2017.01.076
http://www.ncbi.nlm.nih.gov/pubmed/28228268
[2016]
11.Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses..[The Journal of biological chemistry,291(45),(2016),23672-23680]Akhter N, Takeda Y, Nara H, Araki A, Ishii N, Asao N, Asao H
10.1074/jbc.M116.742353
http://www.ncbi.nlm.nih.gov/pubmed/27637330
12.The Tohoku Medical Megabank Project: Design and Mission..[Journal of epidemiology,26(9),(2016),493-511]Kuriyama S, Yaegashi N, Nagami F, Arai T, Kawaguchi Y, Osumi N, Sakaida M, Suzuki Y, Nakayama K, Hashizume H, Tamiya G, Kawame H, Suzuki K, Hozawa A, Nakaya N, Kikuya M, Metoki H, Tsuji I, Fuse N, Kiyomoto H, Sugawara J, Tsuboi A, Egawa S, Ito K, Chida K, Ishii T, Tomita H, Taki Y, Minegishi N, Ishii N, Yasuda J, Igarashi K, Shimizu R, Nagasaki M, Koshiba S, Kinoshita K, Ogishima S, Takai-Igarashi T, Tominaga T, Tanabe O, Ohuchi N, Shimosegawa T, Kure S, Tanaka H, Ito S, Hitomi J, Tanno K, Nakamura M, Ogasawara K, Kobayashi S, Sakata K, Satoh M, Shimizu A, Sasaki M, Endo R, Sobue K, Tohoku Medical Megabank Project Study Group T, Yamamoto M
10.2188/jea.JE20150268
http://www.ncbi.nlm.nih.gov/pubmed/27374138
13.Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models..[Neuro-oncology,18(8),(2016),1120-1128]Shoji T, Saito R, Chonan M, Shibahara I, Sato A, Kanamori M, Sonoda Y, Kondo T, Ishii N, Tominaga T
10.1093/neuonc/now023
http://www.ncbi.nlm.nih.gov/pubmed/26917236
14.TNFR-Associated Factors 2 and 5 Differentially Regulate the Instructive IL-6 Receptor Signaling Required for Th17 Development..[Journal of immunology (Baltimore, Md. : 1950),196(10),(2016),4082-4089]Nagashima H, Okuyama Y, Hayashi T, Ishii N, So T
10.4049/jimmunol.1501610
http://www.ncbi.nlm.nih.gov/pubmed/27076680
15.Mesenteric lymph nodes contribute to proinflammatory Th17-cell generation during inflammation of the small intestine in mice..[European journal of immunology,46(5),(2016),1119-1131]Kawabe T, Suzuki N, Yamaki S, Sun SL, Asao A, Okuyama Y, So T, Iwakura Y, Ishii N
10.1002/eji.201545907
http://www.ncbi.nlm.nih.gov/pubmed/26887964
16.OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia..[EMBO molecular medicine,8(4),(2016),422-436]Hirano T, Kikuchi T, Tode N, Santoso A, Yamada M, Mitsuhashi Y, Komatsu R, Kawabe T, Tanimoto T, Ishii N, Tanaka Y, Nishimura H, Nukiwa T, Watanabe A, Ichinose M
10.15252/emmm.201506154
http://www.ncbi.nlm.nih.gov/pubmed/26976612
17.TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection..[PLoS pathogens,12(1),(2016),e1005349-]Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC
10.1371/journal.ppat.1005349
http://www.ncbi.nlm.nih.gov/pubmed/26741490
[2015]
18.CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models..[Neuro-oncology,17(11),(2015),1453-1462]Chonan M, Saito R, Shoji T, Shibahara I, Kanamori M, Sonoda Y, Watanabe M, Kikuchi T, Ishii N, Tominaga T
10.1093/neuonc/nov090
http://www.ncbi.nlm.nih.gov/pubmed/26008605
19.TNF Receptor-Associated Factor (TRAF) Signaling Network in CD4(+) T-Lymphocytes..[The Tohoku journal of experimental medicine,236(2),(2015),139-154]So T, Nagashima H, Ishii N
10.1620/tjem.236.139
http://www.ncbi.nlm.nih.gov/pubmed/26072698
20.OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy..[Molecular cancer,14,(2015),41-]Shibahara I, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T
10.1186/s12943-015-0307-3
http://www.ncbi.nlm.nih.gov/pubmed/25744203
Page: [1] [2] [3] [4] [5] [6] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University